Chronic kidney disease: How effective and safe are antiplatelet agents in CKD?

Nature Reviews Nephrology

Volumn 9, Issue 6, 2013, Pages 314-316

  Floege, Jürgen ^a   Schlieper, Georg ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; EPTIFIBATIDE; PLACEBO; TICLOPIDINE; TIROFIBAN; WARFARIN;

ACUTE HEART INFARCTION; CARDIOVASCULAR MORTALITY; CENTRAL VENOUS CATHETER; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; LOW DRUG DOSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SHORT SURVEY; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW (TOPIC);

HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RENAL INSUFFICIENCY, CHRONIC; STROKE;

EID: 84878602414     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.83     Document Type: Short Survey

References (10)

1. Palmer, S. C. et al. Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD008834. http://dx.doi.org/10.1002/14651858.CD008834.pub2.
2. Palmer, S. C. et al. Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis. Am. J. Kidney Dis. 61, 112-122 (2013).
3. Kahn, M. R., Robbins, M. J., Kim, M. C. & Fuster, V. Management of cardiovascular disease in patients with kidney disease. Nat. Rev. Cardiol. http://dx.doi.org/10.1038/nrcardio.2013.15.
4. Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238-248 (2005).
5. Wright, R. S. et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann. Intern. Med. 137, 563-570 (2002).
6. Shroff, G. R., Li, S. & Herzog, C. A. Survival of US dialysis patients after acute myocardial infarction: Is it finally getting better in the modern treatment era? [abstract]. Presented at the 2012 American Heart Association Scientific Sessions.
7. U. S. Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. National Institutes of Health, Bethesda, 2012.
8. Hiremath, S., Holden, R. M., Fergusson, D. & Zimmerman, D. L. Antiplatelet medications in hemodialysis patients: A systematic review of bleeding rates. Clin. J. Am. Soc. Nephrol. 4, 1347-1355 (2009).
9. Pisters, R. et al. A novel user-friendly score (HAS-BLED) to assess 1 year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 138, 1093-1100 (2010).
10. Krueger, T., Westenfeld, R., Ketteler, M., Schurgers, L J. & Floege, J. Vitamin K deficiency in CKD patients: A modifiable risk factor for vascular calcification? Kidney Int. 76, 18-22 (2009).